{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:23:28Z","timestamp":1785392608654,"version":"3.55.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jane Watson Ramsey Myeloma Research PhD Scholarship"},{"name":"Cancer Council SA Clinical Investigator Grant"},{"name":"Flinders Foundation Cancer Seed Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Multiple myeloma (MM) is a malignancy characterised by the uncontrolled proliferation of clonal plasma cells, primarily within the bone marrow, and is still considered incurable. A significant proportion of patients relapse with drug-refractory disease, necessitating the development of novel therapeutic approaches. Ferroptosis is a recently-characterised form of non-apoptotic programmed cell death, linked to phospholipid peroxidation, that represents a promising approach for the treatment of MM and other cancers, that are refractory to more conventional apoptosis-inducing regimens. A better understanding of the relationship between cellular lipid composition and ferroptosis sensitivity is key to harnessing this form of programmed cell death as a therapeutic approach. In addition to the cellular proportions of phospholipids containing poly- and monounsaturated fatty acids, studies to date indicate that cholesterol levels impact not only the onset and progression of haematological malignancies but also the sensitivity of a variety of different cancers to ferroptosis. Therefore, manipulating the uptake and metabolism of lipids, including glycerophospholipids and cholesterol, may be an effective means of sensitising MM cells to ferroptosis. Findings from the limited number of studies concerning ferroptosis in MM and compelling evidence from other malignancies, provide a strong rationale for further investigation of ferroptosis as a novel therapeutic approach for MM.<\/jats:p>","DOI":"10.1007\/s12672-025-03444-9","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:28:44Z","timestamp":1756106924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The instrumental role of lipids in governing the sensitivity of multiple myeloma to ferroptosis"],"prefix":"10.1007","volume":"16","author":[{"given":"Ali","family":"Habib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver G.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E.","family":"Toomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig T.","family":"Wallington-Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"1","key":"3444_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","volume":"8","author":"L Rasche","year":"2017","unstructured":"Rasche L, Chavan SS, Stephens OW, Patel PH, Tytarenko R, Ashby C, et al. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat Commun. 2017;8(1):268.","journal-title":"Nat Commun"},{"issue":"5","key":"3444_CR2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma: A review. JAMA. 2022;327(5):464\u201377.","journal-title":"JAMA"},{"issue":"9","key":"3444_CR3","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","volume":"9","author":"J Huang","year":"2022","unstructured":"Huang J, Chan SC, Lok V, Zhang L, Lucero-Prisno DE 3rd, Xu W, et al. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and Temporal trends. Lancet Haematol. 2022;9(9):e670\u20137.","journal-title":"Lancet Haematol"},{"key":"3444_CR4","unstructured":"Australian_Institute_of_Health_and_Welfare. Cancer data in Australia 2025 [Available from: https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia\/contents\/survival"},{"key":"3444_CR5","doi-asserted-by":"publisher","first-page":"m3176","DOI":"10.1136\/bmj.m3176","volume":"370","author":"UA Shah","year":"2020","unstructured":"Shah UA, Mailankody S. Emerging immunotherapies in multiple myeloma. BMJ. 2020;370:m3176.","journal-title":"BMJ"},{"key":"3444_CR6","doi-asserted-by":"crossref","unstructured":"Turesson I, Bjorkholm M, Blimark CH, Kristinsson S, Velez R, Landgren O. Rapidly changing myeloma epidemiology in the general population: increased incidence, older patients, and longer survival. Eur J Haematol. 2018.","DOI":"10.1111\/ejh.13083"},{"issue":"29","key":"3444_CR7","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1200\/JCO.21.02614","volume":"40","author":"M D\u2019Agostino","year":"2022","unstructured":"D\u2019Agostino M, Cairns DA, Lahuerta JJ, Wester R, Bertsch U, Waage A, et al. Second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma: A European myeloma network (EMN) report within the HARMONY project. J Clin Oncol. 2022;40(29):3406\u201318.","journal-title":"J Clin Oncol"},{"key":"3444_CR8","doi-asserted-by":"crossref","unstructured":"Dima D, Jiang D, Singh DJ, Hasipek M, Shah HS, Ullah F et al. Multiple Myeloma Therapy: Emerg Trends Challenges Cancers [Internet]. 2022; 14(17).","DOI":"10.3390\/cancers14174082"},{"issue":"1","key":"3444_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12964-021-00799-8","volume":"19","author":"J Cui","year":"2021","unstructured":"Cui J, Zhao S, Li Y, Zhang D, Wang B, Xie J, et al. Regulated cell death: discovery, features and implications for neurodegenerative diseases. Cell Commun Signal. 2021;19(1):120.","journal-title":"Cell Commun Signal"},{"key":"3444_CR10","doi-asserted-by":"publisher","first-page":"634690","DOI":"10.3389\/fcell.2021.634690","volume":"9","author":"XM Hu","year":"2021","unstructured":"Hu XM, Li ZX, Lin RH, Shan JQ, Yu QW, Wang RX, et al. Guidelines for regulated cell death assays: A systematic summary, A categorical comparison, A prospective. Front Cell Dev Biol. 2021;9:634690.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"3444_CR11","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"3","key":"3444_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler MM, Stockwell BR. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 2017;482(3):419\u201325.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9\u201310","key":"3444_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1101\/gad.314674.118","volume":"32","author":"M Conrad","year":"2018","unstructured":"Conrad M, Kagan VE, Bayir H, Pagnussat GC, Head B, Traber MG, et al. Regulation of lipid peroxidation and ferroptosis in diverse species. Genes Dev. 2018;32(9\u201310):602\u201319.","journal-title":"Genes Dev"},{"issue":"6","key":"3444_CR14","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35(6):830\u201349.","journal-title":"Cancer Cell"},{"issue":"5","key":"3444_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","volume":"38","author":"JPF Angeli","year":"2017","unstructured":"Angeli JPF, Shah R, Pratt DA, Conrad M. Ferroptosis inhibition: mechanisms and opportunities. Trends Pharmacol Sci. 2017;38(5):489\u201398.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"3444_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385.","journal-title":"Cell"},{"key":"3444_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its Pharmacological implication. Free Radic Biol Med. 2019;133:144\u201352.","journal-title":"Free Radic Biol Med"},{"issue":"7784","key":"3444_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693\u20138.","journal-title":"Nature"},{"issue":"1\u20132","key":"3444_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbamem.2003.11.012","volume":"1660","author":"M Turunen","year":"2004","unstructured":"Turunen M, Olsson J, Dallner G. Metabolism and function of coenzyme Q. Biochim Biophys Acta. 2004;1660(1\u20132):171\u201399.","journal-title":"Biochim Biophys Acta"},{"issue":"36","key":"3444_CR20","doi-asserted-by":"publisher","first-page":"28110","DOI":"10.1074\/jbc.M001280200","volume":"275","author":"GJ Warner","year":"2000","unstructured":"Warner GJ, Berry MJ, Moustafa ME, Carlson BA, Hatfield DL, Faust JR. Inhibition of Selenoprotein synthesis by selenocysteine tRNA[Ser]Sec lacking isopentenyladenosine. J Biol Chem. 2000;275(36):28110\u20139.","journal-title":"J Biol Chem"},{"issue":"3","key":"3444_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26(3):165\u201376.","journal-title":"Trends Cell Biol"},{"issue":"3","key":"3444_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4103\/0975-7406.84471","volume":"3","author":"R Saini","year":"2011","unstructured":"Saini R. Coenzyme Q10: the essential nutrient. J Pharm Bioallied Sci. 2011;3(3):466\u20137.","journal-title":"J Pharm Bioallied Sci"},{"issue":"8","key":"3444_CR23","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.bbabio.2016.03.036","volume":"1857","author":"MJ Acosta","year":"2016","unstructured":"Acosta MJ, Vazquez Fonseca L, Desbats MA, Cerqua C, Zordan R, Trevisson E, et al. Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta. 2016;1857(8):1079\u201385.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"3444_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1158\/0008-5472.CAN-19-0650","volume":"80","author":"I Kaymak","year":"2020","unstructured":"Kaymak I, Maier CR, Schmitz W, Campbell AD, Dankworth B, Ade CP, et al. Mevalonate pathway provides ubiquinone to maintain pyrimidine synthesis and survival in p53-Deficient cancer cells exposed to metabolic stress. Cancer Res. 2020;80(2):189\u2013203.","journal-title":"Cancer Res"},{"key":"3444_CR25","unstructured":"Ahmed S, Shah P, Ahmed O, Biochemistry. Lipids. StatPearls. Treasure Island (FL)2022."},{"issue":"Suppl 3","key":"3444_CR26","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1038\/sj.ejcn.1601478","volume":"56","author":"PC Calder","year":"2002","unstructured":"Calder PC, Grimble RF. Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr. 2002;56(Suppl 3):S14\u20139.","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"3444_CR27","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1038\/s41467-021-22471-y","volume":"12","author":"A Beatty","year":"2021","unstructured":"Beatty A, Singh T, Tyurina YY, Tyurin VA, Samovich S, Nicolas E, et al. Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1. Nat Commun. 2021;12(1):2244.","journal-title":"Nat Commun"},{"issue":"6","key":"3444_CR28","doi-asserted-by":"publisher","first-page":"e2100308","DOI":"10.1002\/pmic.202100308","volume":"23","author":"J Rodencal","year":"2023","unstructured":"Rodencal J, Dixon SJ. A Tale of two lipids: lipid unsaturation commands ferroptosis sensitivity. Proteomics. 2023;23(6):e2100308.","journal-title":"Proteomics"},{"key":"3444_CR29","doi-asserted-by":"crossref","unstructured":"Mynott RL, Habib A, Best OG, Wallington-Gates CT. Ferroptosis in haematological malignancies and associated therapeutic nanotechnologies. Int J Mol Sci. 2023;24(8).","DOI":"10.3390\/ijms24087661"},{"issue":"19","key":"3444_CR30","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1182\/bloodadvances.2023010335","volume":"8","author":"J Zhang","year":"2024","unstructured":"Zhang J, Liu Y, Zuo L, Fan F, Yan H, Zhao F, et al. Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma. Blood Adv. 2024;8(19):5022\u201338.","journal-title":"Blood Adv"},{"issue":"14","key":"3444_CR31","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.3390\/ijms26146579","volume":"26","author":"A Habib","year":"2025","unstructured":"Habib A, Mynott RL, Best OG, Revesz IA, Prestidge CA, Wallington-Gates CT, Novel. (1S,3R)-RSL3-Encapsulated polyunsaturated fatty acid rich liposomes sensitise multiple myeloma cells to Ferroptosis-Mediated cell death. Int J Mol Sci. 2025;26(14):6579.","journal-title":"Int J Mol Sci"},{"key":"3444_CR32","doi-asserted-by":"crossref","unstructured":"Shan K, Feng N, Zhu D, Qu H, Fu G, Li J et al. Free docosahexaenoic acid promotes ferroptotic cell death via Lipoxygenase dependent and independent pathways in cancer cells. Eur J Nutr. 2022.","DOI":"10.1007\/s00394-022-02940-w"},{"issue":"1","key":"3444_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13(1):81\u201390.","journal-title":"Nat Chem Biol"},{"issue":"3","key":"3444_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong L, Ko PJ, To M, Cao JY, Forcina GC, Tarangelo A, et al. Exogenous monounsaturated fatty acids promote a Ferroptosis-Resistant cell state. Cell Chem Biol. 2019;26(3):420\u201332. e9.","journal-title":"Cell Chem Biol"},{"issue":"3","key":"3444_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.chembiol.2019.03.001","volume":"26","author":"UN Das","year":"2019","unstructured":"Das UN. Saturated fatty acids, MUFAs and PUFAs regulate ferroptosis. Cell Chem Biol. 2019;26(3):309\u201311.","journal-title":"Cell Chem Biol"},{"key":"3444_CR36","doi-asserted-by":"publisher","first-page":"109013","DOI":"10.1016\/j.jnutbio.2022.109013","volume":"106","author":"B Kr\u00fcmmel","year":"2022","unstructured":"Kr\u00fcmmel B, von Hanstein A-S, Pl\u00f6tz T, Lenzen S, Mehmeti I. Differential effects of saturated and unsaturated free fatty acids on ferroptosis in rat \u03b2-cells. J Nutr Biochem. 2022;106:109013.","journal-title":"J Nutr Biochem"},{"key":"3444_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yjmcc.2020.10.010","volume":"150","author":"N Wang","year":"2021","unstructured":"Wang N, Ma H, Li J, Meng C, Zou J, Wang H, et al. HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes. J Mol Cell Cardiol. 2021;150:65\u201376.","journal-title":"J Mol Cell Cardiol"},{"issue":"14","key":"3444_CR38","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1111\/febs.16772","volume":"290","author":"H Kuang","year":"2023","unstructured":"Kuang H, Sun X, Liu Y, Tang M, Wei Y, Shi Y, et al. Palmitic acid-induced ferroptosis via CD36 activates ER stress to break calcium-iron balance in colon cancer cells. Febs J. 2023;290(14):3664\u201387.","journal-title":"Febs J"},{"key":"3444_CR39","doi-asserted-by":"crossref","unstructured":"Miao S, Zhang Q, Ding W, Hou B, Su Z, Li M et al. Platelet Internalization Mediates Ferroptosis in Myocardial Infarction. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(2):218\u2009\u2013\u200930.","DOI":"10.1161\/ATVBAHA.122.318161"},{"key":"3444_CR40","volume-title":"Lysophospholipids. Encyclopedia of molecular Pharmacology","author":"Heringdorf","year":"2008","unstructured":"Heringdorf, DMz. Lysophospholipids. Encyclopedia of molecular Pharmacology. Berlin, Heidelberg: Springer; 2008."},{"key":"3444_CR41","doi-asserted-by":"publisher","first-page":"602771","DOI":"10.3389\/fendo.2020.602771","volume":"11","author":"CM Spickett","year":"2020","unstructured":"Spickett CM. Formation of oxidatively modified lipids as the basis for a cellular epilipidome. Front Endocrinol (Lausanne). 2020;11:602771.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7784","key":"3444_CR42","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688\u201392.","journal-title":"Nature"},{"issue":"1\u20132","key":"3444_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331.","journal-title":"Cell"},{"key":"3444_CR44","unstructured":"Craig M, Yarrarapu SNS, Dimri M, Biochemistry. Cholesterol. StatPearls. Treasure Island (FL)2024."},{"key":"3444_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/metabo13070799","volume":"13","author":"AM White","year":"2023","unstructured":"White AM, Best OG, Hotinski AK, Kuss BJ, Thurgood LA. The role of cholesterol in chronic lymphocytic leukemia development and pathogenesis. Metabolites. 2023;13:7.","journal-title":"Metabolites"},{"issue":"1","key":"3444_CR46","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s42003-023-05477-8","volume":"6","author":"Q Sun","year":"2023","unstructured":"Sun Q, Liu D, Cui W, Cheng H, Huang L, Zhang R, et al. Cholesterol mediated ferroptosis suppression reveals essential roles of coenzyme Q and squalene. Commun Biol. 2023;6(1):1108.","journal-title":"Commun Biol"},{"issue":"1","key":"3444_CR47","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1038\/s41467-024-50073-x","volume":"15","author":"M Xian","year":"2024","unstructured":"Xian M, Wang Q, Xiao L, Zhong L, Xiong W, Ye L, et al. Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nat Commun. 2024;15(1):5767.","journal-title":"Nat Commun"},{"key":"3444_CR48","doi-asserted-by":"crossref","unstructured":"Pic\u00f3n DF, Skouta R. Unveiling the therapeutic potential of squalene synthase: Deciphering its biochemical mechanism, disease implications, and intriguing ties to ferroptosis. Cancers (Basel). 2023;15(14).","DOI":"10.3390\/cancers15143731"},{"issue":"7746","key":"3444_CR49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-019-0945-5","volume":"567","author":"J Garcia-Bermudez","year":"2019","unstructured":"Garcia-Bermudez J, Baudrier L, Bayraktar EC, Shen Y, La K, Guarecuco R, et al. Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature. 2019;567(7746):118\u201322.","journal-title":"Nature"},{"key":"3444_CR50","doi-asserted-by":"publisher","first-page":"102661","DOI":"10.1016\/j.redox.2023.102661","volume":"62","author":"C Liu","year":"2023","unstructured":"Liu C, Liao W, Chen J, Yu K, Wu Y, Zhang S, et al. Cholesterol confers ferroptosis resistance onto myeloid-biased hematopoietic stem cells and prevents irradiation-induced myelosuppression. Redox Biol. 2023;62:102661.","journal-title":"Redox Biol"},{"key":"3444_CR51","doi-asserted-by":"publisher","first-page":"102678","DOI":"10.1016\/j.redox.2023.102678","volume":"62","author":"X Zhao","year":"2023","unstructured":"Zhao X, Lian X, Xie J, Liu G. Accumulated cholesterol protects tumours from elevated lipid peroxidation in the microenvironment. Redox Biol. 2023;62:102678.","journal-title":"Redox Biol"},{"issue":"3","key":"3444_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1042\/BC20060051","volume":"99","author":"V Michel","year":"2007","unstructured":"Michel V, Bakovic M. Lipid rafts in health and disease. Biol Cell. 2007;99(3):129\u201340.","journal-title":"Biol Cell"},{"issue":"9","key":"3444_CR53","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41419-024-07098-3","volume":"15","author":"X Zhao","year":"2024","unstructured":"Zhao X, Zhao Z, Li B, Huan S, Li Z, Xie J, et al. ACSL4-mediated lipid rafts prevent membrane rupture and inhibit Immunogenic cell death in melanoma. Cell Death Dis. 2024;15(9):695.","journal-title":"Cell Death Dis"},{"issue":"38","key":"3444_CR54","doi-asserted-by":"publisher","first-page":"e2405826","DOI":"10.1002\/advs.202405826","volume":"11","author":"T Bai","year":"2024","unstructured":"Bai T, Xue P, Shao S, Yan S, Zeng X. Cholesterol Depletion-Enhanced ferroptosis and immunotherapy via engineered nanozyme. Adv Sci (Weinh). 2024;11(38):e2405826.","journal-title":"Adv Sci (Weinh)"},{"key":"3444_CR55","unstructured":"Sizar O, Khare S, Patel P, Talati R. Statin medications. StatPearls. Treasure Island (FL): StatPearls publishing copyright \u00a9 2025. StatPearls Publishing LLC.; 2025."},{"issue":"1","key":"3444_CR56","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12951-021-01058-1","volume":"19","author":"X Yao","year":"2021","unstructured":"Yao X, Xie R, Cao Y, Tang J, Men Y, Peng H, et al. Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J Nanobiotechnol. 2021;19(1):311.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3444_CR57","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41419-025-07562-8","volume":"16","author":"D Sun","year":"2025","unstructured":"Sun D, Cui X, Yang W, Wei M, Yan Z, Zhang M, et al. Simvastatin inhibits PD-L1 via ILF3 to induce ferroptosis in gastric cancer cells. Cell Death Dis. 2025;16(1):208.","journal-title":"Cell Death Dis"},{"key":"3444_CR58","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1182\/blood-2018-99-118482","volume":"132","author":"C Panaroni","year":"2018","unstructured":"Panaroni C, Fulzele K, Soucy R, Siu KT, Mukaihara K, Huang C, et al. Arachidonic acid induces Ferroptosis-Mediated Cell-Death in multiple myeloma. Blood. 2018;132:4498.","journal-title":"Blood"},{"issue":"4","key":"3444_CR59","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40(4):365\u2013e786.","journal-title":"Cancer Cell"},{"issue":"8","key":"3444_CR60","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","volume":"33","author":"E Dierge","year":"2021","unstructured":"Dierge E, Debock E, Guilbaud C, Corbet C, Mignolet E, Mignard L, et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 2021;33(8):1701\u2013e155.","journal-title":"Cell Metab"},{"key":"3444_CR61","doi-asserted-by":"crossref","unstructured":"Chen J, Zaal EA, Berkers CR, Ruijtenbeek R, Garssen J, Redegeld FA. Omega-3 fatty acids DHA and EPA reduce bortezomib resistance in multiple myeloma cells by promoting glutathione degradation. Cells. 2021;10(9).","DOI":"10.3390\/cells10092287"},{"issue":"1","key":"3444_CR62","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1038\/s41598-024-55050-4","volume":"14","author":"A Suda","year":"2024","unstructured":"Suda A, Umaru BA, Yamamoto Y, Shima H, Saiki Y, Pan Y, et al. Polyunsaturated fatty acids-induced ferroptosis suppresses pancreatic cancer growth. Sci Rep. 2024;14(1):4409.","journal-title":"Sci Rep"},{"key":"3444_CR63","doi-asserted-by":"publisher","first-page":"111181","DOI":"10.1016\/j.intimp.2023.111181","volume":"125","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Shen G, Meng T, Lv Z, Li X, Li J, et al. Eicosapentaenoic acid enhances the sensitivity of osteosarcoma to cisplatin by inducing ferroptosis through the DNA-PKcs\/AKT\/NRF2 pathway and reducing PD-L1 expression to attenuate immune evasion. Int Immunopharmacol. 2023;125:111181.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"3444_CR64","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1021\/acs.molpharmaceut.2c00333","volume":"19","author":"Y Chen","year":"2022","unstructured":"Chen Y, Liao X, Jing P, Hu L, Yang Z, Yao Y, et al. Linoleic Acid-Glucosamine hybrid for endogenous Iron-Activated ferroptosis therapy in High-Grade serous ovarian cancer. Mol Pharm. 2022;19(9):3187\u201398.","journal-title":"Mol Pharm"},{"issue":"7823","key":"3444_CR65","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker JM, Tasdogan A, Ramesh V, Shen B, Mitchell EC, Martin-Sandoval MS, et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020;585(7823):113\u20138.","journal-title":"Nature"},{"issue":"20","key":"3444_CR66","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","volume":"79","author":"L Tesfay","year":"2019","unstructured":"Tesfay L, Paul BT, Konstorum A, Deng Z, Cox AO, Lee J, et al. Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death. Cancer Res. 2019;79(20):5355\u201366.","journal-title":"Cancer Res"},{"issue":"1","key":"3444_CR67","doi-asserted-by":"publisher","first-page":"2101769","DOI":"10.1080\/2162402X.2022.2101769","volume":"11","author":"H Luo","year":"2022","unstructured":"Luo H, Wang X, Song S, Wang Y, Dan Q, Ge H. Targeting stearoyl-coa desaturase enhances radiation induced ferroptosis and Immunogenic cell death in esophageal squamous cell carcinoma. Oncoimmunology. 2022;11(1):2101769.","journal-title":"Oncoimmunology"},{"issue":"5","key":"3444_CR68","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280\u201396.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3444_CR69","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canlet.2016.07.035","volume":"381","author":"JL Roh","year":"2016","unstructured":"Roh JL, Kim EH, Jang HJ, Park JY, Shin D. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer. Cancer Lett. 2016;381(1):96\u2013103.","journal-title":"Cancer Lett"},{"issue":"4","key":"3444_CR70","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10637-021-01070-0","volume":"39","author":"MR Liu","year":"2021","unstructured":"Liu MR, Zhu WT, Pei DS. System Xc(-): a key regulatory target of ferroptosis in cancer. Invest New Drugs. 2021;39(4):1123\u201331.","journal-title":"Invest New Drugs"},{"issue":"1","key":"3444_CR71","doi-asserted-by":"publisher","first-page":"7924","DOI":"10.1038\/s41598-024-58579-6","volume":"14","author":"TC Genaro-Mattos","year":"2024","unstructured":"Genaro-Mattos TC, Korade Z, Sahar NE, Angeli JPF, Mirnics K, Peeples ES. Enhancing 7-dehydrocholesterol suppresses brain ferroptosis and tissue injury after neonatal hypoxia-ischemia. Sci Rep. 2024;14(1):7924.","journal-title":"Sci Rep"},{"issue":"7998","key":"3444_CR72","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","volume":"626","author":"FP Freitas","year":"2024","unstructured":"Freitas FP, Alborzinia H, dos Santos AF, Nepachalovich P, Pedrera L, Zilka O, et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature. 2024;626(7998):401\u201310.","journal-title":"Nature"},{"issue":"11","key":"3444_CR73","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1111\/cas.15944","volume":"114","author":"H Jin","year":"2023","unstructured":"Jin H, Zhu M, Zhang D, Liu X, Guo Y, Xia L, et al. B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer. Cancer Sci. 2023;114(11):4225\u201336.","journal-title":"Cancer Sci"},{"key":"3444_CR74","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1074\/jbc.RA120.014888","volume":"296","author":"JS Rink","year":"2021","unstructured":"Rink JS, Lin AY, McMahon KM, Calvert AE, Yang S, Taxter T, et al. Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis. J Biol Chem. 2021;296:100100.","journal-title":"J Biol Chem"},{"key":"3444_CR75","doi-asserted-by":"crossref","unstructured":"Liu X, Xu P, Wang L, Zhang C, Wang M, Ouyang J et al. Cholesterol levels provide prognostic information in patients with multiple myeloma. Clin Lab. 2020;66(4).","DOI":"10.7754\/Clin.Lab.2019.190824"},{"issue":"2","key":"3444_CR76","first-page":"219","volume":"9","author":"X Ding","year":"2019","unstructured":"Ding X, Zhang W, Li S, Yang H. The role of cholesterol metabolism in cancer. Am J Cancer Res. 2019;9(2):219\u201327.","journal-title":"Am J Cancer Res"},{"key":"3444_CR77","doi-asserted-by":"publisher","first-page":"1057546","DOI":"10.3389\/fimmu.2022.1057546","volume":"13","author":"H Halimi","year":"2022","unstructured":"Halimi H, Farjadian S, Cholesterol. An important actor on the cancer immune scene. Front Immunol. 2022;13:1057546.","journal-title":"Front Immunol"},{"issue":"6","key":"3444_CR78","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.7150\/ijbs.92274","volume":"20","author":"W Jiang","year":"2024","unstructured":"Jiang W, Jin WL, Xu AM. Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities. Int J Biol Sci. 2024;20(6):2044\u201371.","journal-title":"Int J Biol Sci"},{"key":"3444_CR79","doi-asserted-by":"crossref","unstructured":"Choi T, Choi IY, Han K, Jeong SM, Yoo JE, Rhee SY et al. Lipid level, lipid variability, and risk of multiple myeloma: A nationwide Population-Based study of 3,527,776 subjects. Cancers (Basel). 2021;13(3).","DOI":"10.3390\/cancers13030540"},{"issue":"3","key":"3444_CR80","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00277-007-0375-6","volume":"87","author":"I Yavasoglu","year":"2008","unstructured":"Yavasoglu I, Tombuloglu M, Kadikoylu G, Donmez A, Cagirgan S, Bolaman Z. Cholesterol levels in patients with multiple myeloma. Ann Hematol. 2008;87(3):223\u20138.","journal-title":"Ann Hematol"},{"issue":"22","key":"3444_CR81","doi-asserted-by":"publisher","first-page":"20964","DOI":"10.1002\/cam4.6649","volume":"12","author":"L Li","year":"2023","unstructured":"Li L, Yu Z, Ren J, Niu T. Low cholesterol levels are associated with increasing risk of plasma cell neoplasm: A UK biobank cohort study. Cancer Med. 2023;12(22):20964\u201375.","journal-title":"Cancer Med"},{"issue":"1","key":"3444_CR82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00277-011-1246-8","volume":"91","author":"JM Tirado-Velez","year":"2012","unstructured":"Tirado-Velez JM, Benitez-Rondan A, Cozar-Castellano I, Medina F, Perdomo G. Low-density lipoprotein cholesterol suppresses apoptosis in human multiple myeloma cells. Ann Hematol. 2012;91(1):83\u20138.","journal-title":"Ann Hematol"},{"issue":"2","key":"3444_CR83","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/jcm14020327","volume":"14","author":"D Fotiou","year":"2025","unstructured":"Fotiou D, Katodritou E. From biology to clinical practice: the bone marrow microenvironment in multiple myeloma. J Clin Med. 2025;14(2):327.","journal-title":"J Clin Med"},{"key":"3444_CR84","doi-asserted-by":"publisher","first-page":"217388","DOI":"10.1016\/j.canlet.2024.217388","volume":"611","author":"H Jiang","year":"2025","unstructured":"Jiang H, Li Q, Yang X, Jia L, Cheng H, Wang J, et al. Bone marrow stromal cells protect myeloma cells from ferroptosis through GPX4 desumoylation. Cancer Lett. 2025;611:217388.","journal-title":"Cancer Lett"},{"issue":"21","key":"3444_CR85","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41388-024-03020-5","volume":"43","author":"H Jiang","year":"2024","unstructured":"Jiang H, Wang L, Zhang Q, Wang S, Jia L, Cheng H, et al. Bone marrow stromal cells dictate lanosterol biosynthesis and ferroptosis of multiple myeloma. Oncogene. 2024;43(21):1644\u201353.","journal-title":"Oncogene"},{"key":"3444_CR86","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/B978-008045382-8.00007-1","volume-title":"Comprehensive natural products II","author":"T Kushiro","year":"2010","unstructured":"Kushiro T, Ebizuka Y. 1.18 - Triterpenes. In: Liu H-W, Mander L, editors. Comprehensive natural products II. Oxford: Elsevier; 2010. pp. 673\u2013708."},{"key":"3444_CR87","doi-asserted-by":"publisher","first-page":"1240275","DOI":"10.3389\/fimmu.2023.1240275","volume":"14","author":"T Zeller","year":"2023","unstructured":"Zeller T, M\u00fcnnich IA, Windisch R, Hilger P, Schewe DM, Humpe A, et al. Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer. Front Immunol. 2023;14:1240275.","journal-title":"Front Immunol"},{"issue":"11","key":"3444_CR88","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.chembiol.2019.09.007","volume":"26","author":"R Shah","year":"2019","unstructured":"Shah R, Farmer LA, Zilka O, Van Kessel ATM, Pratt DA, Beyond DPPH. Use of Fluorescence-Enabled inhibited autoxidation to predict oxidative cell death rescue. Cell Chem Biol. 2019;26(11):1594\u2013e6077.","journal-title":"Cell Chem Biol"},{"issue":"10","key":"3444_CR89","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1016\/j.bbamem.2012.03.004","volume":"1818","author":"TM McIntyre","year":"2012","unstructured":"McIntyre TM. Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivation. Biochim Biophys Acta. 2012;1818(10):2456\u201364.","journal-title":"Biochim Biophys Acta"},{"key":"3444_CR90","doi-asserted-by":"crossref","unstructured":"G\u00e1mez B, Whipp D, Rao S, Morris EV, Park YE, Kaya Z et al. High cholesterol increases myeloma tumour burden and promotes resistance to bortezomib. BioRxiv. 2025:2025.01.21.633916.","DOI":"10.1101\/2025.01.21.633916"},{"issue":"6162","key":"3444_CR91","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.1241908","volume":"342","author":"ER Nelson","year":"2013","unstructured":"Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science. 2013;342(6162):1094\u20138.","journal-title":"Science"},{"issue":"1","key":"3444_CR92","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1038\/s41467-021-25354-4","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, Chakraborty B, Safi R, Kazmin D, Chang CY, McDonnell DP. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 2021;12(1):5103.","journal-title":"Nat Commun"},{"issue":"3","key":"3444_CR93","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1158\/2159-8290.CD-19-1500","volume":"11","author":"X Hong","year":"2021","unstructured":"Hong X, Roh W, Sullivan RJ, Wong KHK, Wittner BS, Guo H, et al. The lipogenic regulator SREBP2 induces transferrin in Circulating melanoma cells and suppresses ferroptosis. Cancer Discov. 2021;11(3):678\u201395.","journal-title":"Cancer Discov"},{"issue":"12","key":"3444_CR94","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.7150\/ijms.86409","volume":"20","author":"L Liang","year":"2023","unstructured":"Liang L, Liu Y, Wu X, Chen Y. Artesunate induces ferroptosis by inhibiting the nuclear localization of SREBP2 in myeloma cells. Int J Med Sci. 2023;20(12):1535\u201350.","journal-title":"Int J Med Sci"},{"issue":"3","key":"3444_CR95","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41419-023-05738-8","volume":"14","author":"J Cai","year":"2023","unstructured":"Cai J, Ye Z, Hu Y, Ye L, Gao L, Wang Y, et al. Fatostatin induces ferroptosis through Inhibition of the AKT\/mTORC1\/GPX4 signaling pathway in glioblastoma. Cell Death Dis. 2023;14(3):211.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3444_CR96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11745-999-332-5","volume":"34","author":"T Sasagawa","year":"1999","unstructured":"Sasagawa T, Okita M, Murakami J, Kato T, Watanabe A. Abnormal serum lysophospholipids in multiple myeloma patients. Lipids. 1999;34(1):17\u201321.","journal-title":"Lipids"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03444-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T14:38:01Z","timestamp":1757428681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03444-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3444"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03444-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"1 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"There is nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors give full consent to participate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors give full consent to publishing this work in Discover Oncology.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1612"}}